155 related articles for article (PubMed ID: 32466721)
21. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies.
Hansson J; Galanti MR; Hergens MP; Fredlund P; Ahlbom A; Alfredsson L; Bellocco R; Eriksson M; Hallqvist J; Hedblad B; Jansson JH; Nilsson P; Pedersen N; Trolle Lagerros Y; Ostergren PO; Magnusson C
Eur J Epidemiol; 2012 Oct; 27(10):771-9. PubMed ID: 22722951
[TBL] [Abstract][Full Text] [Related]
22. Use of Scandinavian moist smokeless tobacco (snus) and the risk of atrial fibrillation.
Hergens MP; Galanti R; Hansson J; Fredlund P; Ahlbom A; Alfredsson L; Bellocco R; Eriksson M; Fransson EI; Hallqvist J; Jansson JH; Knutsson A; Pedersen N; Lagerros YT; Ostergren PO; Magnusson C
Epidemiology; 2014 Nov; 25(6):872-6. PubMed ID: 25166877
[TBL] [Abstract][Full Text] [Related]
23. Overweight and perception of overweight as predictors of smokeless tobacco use and of cigarette smoking in a cohort of Swedish adolescents.
Caria MP; Bellocco R; Zambon A; Horton NJ; Galanti MR
Addiction; 2009 Apr; 104(4):661-8. PubMed ID: 19215597
[TBL] [Abstract][Full Text] [Related]
24. Tobacco and type 2 diabetes: is the association explained by genetic factors?
Carlsson S; Kuja-Halkola R; Magnusson C; Lagerros YT; Andersson T
Int J Epidemiol; 2019 Jun; 48(3):926-933. PubMed ID: 30726916
[TBL] [Abstract][Full Text] [Related]
25. Epidemiological evidence relating snus to health--an updated review based on recent publications.
Lee PN
Harm Reduct J; 2013 Dec; 10():36. PubMed ID: 24314326
[TBL] [Abstract][Full Text] [Related]
26. Swedish Snuff (Snus), Cigarette Smoking, and Risk of Type 2 Diabetes.
Titova OE; Baron JA; Fall T; Michaëlsson K; Larsson SC
Am J Prev Med; 2023 Jul; 65(1):60-66. PubMed ID: 36754744
[TBL] [Abstract][Full Text] [Related]
27. Association of Smokeless Tobacco Use and Oral Cancer: A Systematic Global Review and Meta-Analysis.
Asthana S; Labani S; Kailash U; Sinha DN; Mehrotra R
Nicotine Tob Res; 2019 Aug; 21(9):1162-1171. PubMed ID: 29790998
[TBL] [Abstract][Full Text] [Related]
28. [Swedish snuff (snus) and its effects on oral health: an update].
Sieber AL; Jeyakumar J; Bornstein MM; Ramseier CA
Swiss Dent J; 2016; 126(9):799-811. PubMed ID: 27655107
[TBL] [Abstract][Full Text] [Related]
29. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction.
Arefalk G; Hambraeus K; Lind L; Michaëlsson K; Lindahl B; Sundström J
Circulation; 2014 Jul; 130(4):325-32. PubMed ID: 24958793
[TBL] [Abstract][Full Text] [Related]
30. Changing patterns of tobacco use in a middle-aged population: the role of snus, gender, age, and education.
Norberg M; Lundqvist G; Nilsson M; Gilljam H; Weinehall L
Glob Health Action; 2011; 4():. PubMed ID: 21695071
[TBL] [Abstract][Full Text] [Related]
31. Cigarettes and oral snuff use in Sweden: Prevalence and transitions.
Furberg H; Lichtenstein P; Pedersen NL; Bulik C; Sullivan PF
Addiction; 2006 Oct; 101(10):1509-15. PubMed ID: 16968353
[TBL] [Abstract][Full Text] [Related]
32. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study.
Eliasson M; Asplund K; Nasic S; Rodu B
J Intern Med; 2004 Aug; 256(2):101-10. PubMed ID: 15257722
[TBL] [Abstract][Full Text] [Related]
33. Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor.
Hemminki K; Försti A; Hemminki A; Ljungberg B; Hemminki O
BMC Cancer; 2021 May; 21(1):604. PubMed ID: 34034676
[TBL] [Abstract][Full Text] [Related]
34. Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium.
Wyss AB; Hashibe M; Lee YA; Chuang SC; Muscat J; Chen C; Schwartz SM; Smith E; Zhang ZF; Morgenstern H; Wei Q; Li G; Kelsey KT; McClean M; Winn DM; Schantz S; Yu GP; Gillison ML; Zevallos JP; Boffetta P; Olshan AF
Am J Epidemiol; 2016 Nov; 184(10):703-716. PubMed ID: 27744388
[TBL] [Abstract][Full Text] [Related]
35. Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA).
Rasouli B; Andersson T; Carlsson PO; Grill V; Groop L; Martinell M; Midthjell K; Storm P; Tuomi T; Carlsson S
Diabet Med; 2017 Apr; 34(4):514-521. PubMed ID: 27353226
[TBL] [Abstract][Full Text] [Related]
36. Summary of the epidemiological evidence relating snus to health.
Lee PN
Regul Toxicol Pharmacol; 2011 Mar; 59(2):197-214. PubMed ID: 21163315
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
Lunell E; Fagerström K; Hughes J; Pendrill R
Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
[TBL] [Abstract][Full Text] [Related]
38. Impact of snus use in teenage boys on tobacco use in young adulthood; a cohort from the HUNT Study Norway.
Grøtvedt L; Forsén L; Ariansen I; Graff-Iversen S; Lingaas Holmen T
BMC Public Health; 2019 Sep; 19(1):1265. PubMed ID: 31519157
[TBL] [Abstract][Full Text] [Related]
39. Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden.
Gilljam H; Galanti MR
Addiction; 2003 Sep; 98(9):1183-9. PubMed ID: 12930201
[TBL] [Abstract][Full Text] [Related]
40. Risk of gastroesophageal cancer among smokers and users of Scandinavian moist snuff.
Zendehdel K; Nyrén O; Luo J; Dickman PW; Boffetta P; Englund A; Ye W
Int J Cancer; 2008 Mar; 122(5):1095-9. PubMed ID: 17973262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
